Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.691 USD | +1.16% | -9.43% | -51.77% |
03-27 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
03-26 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
- Stock Market
- Equities
- LUCD Stock
- News Lucid Diagnostics Inc.
- Press Releases